The foundational Central Nervous System Therapeutics Market Data highlights a crucial CAGR of 6.57% projected between 2025 and 2035, confirming the sector's steady and powerful growth trajectory over the next decade. This growth rate, while robust, reflects the scientific complexity and high cost of R&D necessary to bring CNS drugs to market compared to other therapeutic areas. Furthermore,...